Advertisement

Meeting Coverage

Challenges in Treating Tardive Dyskinesia

By: Cecilia Peterson; Amanda Glazar; Chirag Shah; Prakash Masand; Michael Lemon Introduction: Tardive Dyskinesia (TD) refers to abnormal, involuntary, choreoathetoid movements of the tongue, lips, face, trunk, and extremities...

Read More

sNfL projects development of definite MS

In patients who experienced a first clinical demyelinating event, baseline levels of serum neurofilament light chain (sNfL), a biomarker of neural damage, were associated with conversion to McDonald 2005 multiple sclerosis (MS)....

Read More

An Insider’s Guide to ASCO 2021: Breast Cancer

The ASCO Annual Meeting enters its second year in a virtual setting June 4-8, 2021, to ensure the safety and health of attendees while delivering groundbreaking science in oncology and timely information on clinical application...

Read More

PhysQuiz Answers! APA 2021: Tardive Dyskinesia

How did you do?   1) A post-hoc analysis of AIMS data from a long-term valbenazine study, KINECT 4 to assess the patterns of improvement of patients with TD found that what percentage of patients receiving valbenazine met...

Read More
Advertisement